Works matching IS 00219541 AND DT 2004 AND VI 198 AND IP 2


Results: 16
    1
    2
    3
    4
    5
    6
    7

    Inhibition of proliferation and induction of apoptosis in breast cancer cells by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 (‘Iressa’) is independent of EGFR expression level(‘Iressa’ is a trademark of the AstraZeneca group of companies.)

    Published in:
    Journal of Cellular Physiology, 2004, v. 198, n. 2, p. 259, doi. 10.1002/jcp.10411
    By:
    • Manuela Campiglio;
    • Alberta Locatelli;
    • Clelia Olgiati;
    • Nicola Normanno;
    • Giulia Somenzi;
    • Lucia Viganò;
    • Marzia Fumagalli;
    • Sylvie Ménard;
    • Luca Gianni
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16